Isoginkgetin是一种双黄酮类化合物,可抑制胰脂肪酶活性,IC50值为2.9µM。
Cas No.:548-19-6
Sample solution is provided at 25 µL, 10mM.
Isoginkgetin is a biflavonoid that inhibits pancreatic lipase activity with an IC50 value of 2.9µM [1]. Isoginkgetin inhibits pre-mRNA splicing by preventing stable recruitment of the U4/U5/U6 tri-small nuclear ribonucleoprotein, resulting in accumulation of the prespliceosomal A complex [2]. Isoginkgetin has been widely used to inhibit the proliferation of tumor cells and to alter the shape of cells [3].
In vitro, Isoginkgetin (20µM) treatment for 24 hours significantly inhibited the expression of MMP-9 in HT1080 cells, increased the expression of TIMP-1, and was accompanied by a decrease in the activity of the PI3K/Akt/NF-κB pathway[4]. Treatment with 10µM Isoginkgetin for 24 hours significantly induced apoptosis in HeLa cells, resulting in the formation of aggregates around the cell nucleus, which induced endoplasmic reticulum stress and damaged the unfolded protein response [5].
In vivo, Isoginkgetin treatment via daily intraperitoneal injection at a dose of 4mg/kg for 14 days significantly inhibited the depression-like behaviors induced by lipopolysaccharide (LPS) in mice and alleviated the neurological pathological changes[6].
References:
[1] Liu P K, Weng Z M, Ge G B, et al. Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: Inhibition potentials and mechanism[J]. International journal of biological macromolecules, 2018, 118: 2216-2223.
[2] O'Brien K, Matlin A J, Lowell A M, et al. The biflavonoid isoginkgetin is a general inhibitor of Pre-mRNA splicing[J]. Journal of Biological Chemistry, 2008, 283(48): 33147-33154.
[3] Wang Y Y, Li R H, Zhang G J, et al. The whole ginkgo resource: flowers, seeds, leaves, branches, and trees—a comprehensive review of their active ingredients, pharmacology, and applications[J]. Chemistry & Biodiversity, 2025, 22(10): e00485.
[4] Yoon S O, Shin S, Lee H J, et al. Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt–dependent matrix metalloproteinase-9 expression[J]. Molecular cancer therapeutics, 2006, 5(11): 2666-2675.
[5] Tsalikis J, Abdel-Nour M, Farahvash A, et al. Isoginkgetin, a natural biflavonoid proteasome inhibitor, sensitizes cancer cells to apoptosis via disruption of lysosomal homeostasis and impaired protein clearance[J]. Molecular and cellular biology, 2019, 39(10): e00489-18.
[6] Li P, Zhang F, Li Y, et al. Isoginkgetin treatment attenuated lipopolysaccharide-induced monoamine neurotransmitter deficiency and depression-like behaviors through downregulating p38/NF-κB signaling pathway and suppressing microglia-induced apoptosis[J]. Journal of psychopharmacology, 2021, 35(10): 1285-1299.
Isoginkgetin是一种双黄酮类化合物,可抑制胰脂肪酶活性,IC50值为2.9µM[1]。Isoginkgetin通过阻止U4/U5/U6三小核核糖核蛋白的稳定招募来抑制前体mRNA剪接,导致剪接前A复合物积累[2]。Isoginkgetin已被广泛用于抑制肿瘤细胞增殖并改变细胞形态[3]。
在体外,20µM的Isoginkgetin处理HT1080细胞24小时,显著抑制了MMP-9的表达,增加了TIMP-1的表达,并伴有PI3K/Akt/NF-κB通路活性的降低[4]。10µM的Isoginkgetin理HeLa细胞24小时,显著诱导了细胞凋亡,导致细胞核周围聚集物形成,诱导内质网应激并损害未折叠蛋白反应[5]。
在体内,每日腹腔注射4mg/kg剂量的Isoginkgetin,连续14天,显著抑制了脂多糖(LPS)诱导的小鼠抑郁样行为,并减轻了神经病理改变[6]。
| Cell experiment [1]: | |
Cell lines | HeLa cells |
Preparation Method | HeLa cells were grown in DMEM medium with 10% (v/v) fetal bovine serum (FBS), 2mM l-glutamine, 50IU penicillin, and 50mg/ml streptomycin at 37°C in 5% CO2/atmosphere. Cells were seeded in 96-well plates at a density of 3×103 cells and cultured overnight. After 24h of treatment with Isoginkgetin (10µM), the cell viability was measured. |
Reaction Conditions | 10µM; 24h |
Applications | Isoginkgetin treatment significantly inhibited the cell viability of HeLa cells. |
| Animal experiment [2]: | |
Animal models | Male Kunming mice |
Preparation Method | Male Kunming mice (8 weeks old; 30-50g) were housed singly in a standard environment with food and water ad libitum. About 40 mice were randomly divided into four experimental groups: (1) control + saline; (2) Isoginkgetin (4mg/kg); (3) LPS; and (4) LPS+Isoginkgetin (4mg/kg). Isoginkgetin, administered at a dose of 4mg/kg, was injected daily for 14 days intraperitoneally (i.p.) prior to LPS (0.83mg/kg) administration. After 24h of LPS or saline i.p. administration, depression-like behaviors in mice were tested. |
Dosage form | 4mg/kg/day for 14 days; i.p. |
Applications | Isoginkgetin treatment significantly reduced depression-like behaviors induced by LPS in mice. |
References: | |
| Cas No. | 548-19-6 | SDF | |
| 别名 | 异银杏素 | ||
| Canonical SMILES | O=C1C=C(C2=CC=C(OC)C=C2)OC3=C(C4=CC(C5=CC(C6=C(O)C=C(O)C=C6O5)=O)=CC=C4OC)C(O)=CC(O)=C13 | ||
| 分子式 | C32H22O10 | 分子量 | 566.51 |
| 溶解度 | DMSO : ≥ 83.3 mg/mL (147.04 mM) | 储存条件 | Store at 2-8°C,protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.7652 mL | 8.826 mL | 17.6519 mL |
| 5 mM | 353 μL | 1.7652 mL | 3.5304 mL |
| 10 mM | 176.5 μL | 882.6 μL | 1.7652 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















